OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 124 filers reported holding OREXIGEN THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $47,000 | -29.9% | 108,358 | -9.3% | 0.00% | 0.0% |
| Q1 2016 | $67,000 | -70.5% | 119,482 | -9.4% | 0.00% | -66.7% |
| Q4 2015 | $227,000 | +2.3% | 131,860 | +25.1% | 0.00% | 0.0% |
| Q3 2015 | $222,000 | -60.3% | 105,404 | -6.7% | 0.00% | -62.5% |
| Q2 2015 | $559,000 | -42.1% | 112,965 | -8.4% | 0.01% | -27.3% |
| Q1 2015 | $966,000 | +47.7% | 123,361 | +14.3% | 0.01% | +37.5% |
| Q4 2014 | $654,000 | +37.4% | 107,882 | -3.5% | 0.01% | +33.3% |
| Q3 2014 | $476,000 | -39.5% | 111,815 | -12.2% | 0.01% | -40.0% |
| Q2 2014 | $787,000 | -32.8% | 127,312 | -29.4% | 0.01% | -33.3% |
| Q1 2014 | $1,172,000 | +300.0% | 180,231 | +246.3% | 0.02% | +275.0% |
| Q4 2013 | $293,000 | -49.6% | 52,045 | -45.0% | 0.00% | -71.4% |
| Q3 2013 | $581,000 | +38.7% | 94,547 | +31.9% | 0.01% | +75.0% |
| Q2 2013 | $419,000 | – | 71,687 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 3,000,000 | $5,160,000 | 4.58% |
| Foresite Capital Management II, LLC | 6,225,049 | $10,707,000 | 3.59% |
| Scale Management, LLC | 1,312,575 | $2,258,000 | 3.46% |
| NEA Management Company, LLC | 3,709,000 | $6,379,000 | 0.41% |
| Cheyne Capital Management (UK) LLP | 413,200 | $709,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 1,189,000 | $2,045,000 | 0.31% |
| SAMLYN CAPITAL, LLC | 6,160,417 | $10,596,000 | 0.22% |
| Rock Springs Capital Management LP | 1,650,000 | $2,838,000 | 0.22% |
| Palo Alto Investors LP | 1,673,024 | $2,878,000 | 0.16% |
| GLOBEFLEX CAPITAL L P | 295,000 | $507,000 | 0.14% |